When should QA escalate commercial pressure to senior management?

Why

ICH Q10 makes senior management ultimately responsible for an effective quality system and says management should ensure a timely and effective escalation process for quality issues. It also notes that regional regulations require an independent quality unit with authority. US regulation gives that unit the authority to approve or reject product.

The point of independence is that quality decisions do not bend to schedules, and escalation is how QA protects that when the pressure comes from above or beside it. Signs that escalation is needed include requests to downgrade a deviation's classification, to close an investigation with a probable cause that the evidence does not support, to release on a date rather than on data, or to skip a validation step for a launch. Escalation should not be an accusation.

A short written summary of the decision, the evidence available and missing, the risk including supply risk to patients, and the realistic options lets senior leaders decide with full information, and puts their decision on record. Quietly giving way is a quality failure, and so is refusing every business need without offering a path. If escalation inside the company fails and a patient risk remains, the responsible person may have regulatory duties of their own, such as a QP's personal responsibility for certification in the EU.